Analyzing social cognition and understanding of social inferences in patients with multiple sclerosis. A comparative study.

CONCLUSION: The level of Theory of Mind in the form of sarcasm understanding decreases significantly in MS patients compared with healthy group potentially mirroring impairment in ToM in general. The results indicate that MS group is not resilient to understand metaphoric speech. More specifically, their pathology seems to be able to affect complex ToM abilities. PMID: 31802039 [PubMed - in process]
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research

Related Links:

BACKGROUND: Impaired balance is common in people with multiple sclerosis (MS) and can be present even in those with a mild disability level. With increasing disability, gait, and balance impairment progress, and lead to increased risk of falls. In some rec...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
We present a case of a 32-year-old man who was found to have both clinically isolated syndrome and chronic inflammatory demyelinating polyneuropathy, highlighting the importance of continued efforts to establish the prevalence of demyelinating disease in the region given the limited treatment options currently available for autoimmune disease.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
ConclusionsIn this multi-ethnic cohort from Toronto, Canada, blacks with NMOSD were less likely than Asians to demonstrate classic NMO by 2006 diagnostic criteria. Caucasians had better long-term disability outcomes compared to Asians as measured by the EDSS.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
;a-Chong MG Abstract INTRODUCTION: Several studies have found that individuals with multiple sclerosis (MS) experience relatively high rates of anxiety and depression; however, there are few reports about social anxiety in individuals with MS. AIM: To analyze the prevalence of social anxiety disorder and other psychiatric comorbidities in MS patients compared to matched controls. SUBJECTS AND METHODS: We included 50 patients with MS that were seen during regularly scheduled visits and 50 sex- and age-matched participants from the general population within a six-month interval. All included participants c...
Source: Revista de Neurologia - Category: Neurology Authors: Tags: Rev Neurol Source Type: research
WEDNESDAY, Jan. 15, 2020 -- From 2011 to 2017, there was an increase in gross annual expenditures on multiple sclerosis (MS) disease-modifying therapies (DMTs), with increased spending mainly driven by increases in per-prescription costs, according...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
Condition:   Multiple Sclerosis Intervention:   Drug: 11C-PBR28 Sponsors:   Massachusetts General Hospital;   Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
WEDNESDAY, Jan. 15, 2020 -- The cost of essential medications for multiple sclerosis have nearly tripled this decade, despite the release of the first generic MS drug, a new study shows. The 2015 release of glatiramer acetate -- the generic version...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
DiscussionThe results suggest that IV MP causality should be considered in case of acute liver injury while data for oral MP is insufficient; systematic liver monitoring for high-dose IV MP may be recommended.
Source: Clinics and Research in Hepatology and Gastroenterology - Category: Gastroenterology Source Type: research
Publication date: Available online 13 January 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Sebastian Michels, Eugen Zizer, Thomas FE Barth, Anette Wassner, Tanja Fangerau, Daniela Taranu, Franziska Bachhuber, Hayrettin Tumani, Makbule SenelAbstractA 23-year old female was diagnosed with relapsing-remitting multiple sclerosis with two symptomatic attacks. Immunomodulatory treatment with Clift® (Glatiramer Acetate biosimilar) was initiated. Shortly after administration, an asymptomatic increase in liver enzymes was noticed, and therapy was paused. However, we observed an enormous increase in liver enzym...
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Publication date: Available online 13 January 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): B.I. Yamout, J. Massouh, I. Hushaymi, M. Zeineddine, G. Saab
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Brain | Education | Multiple Sclerosis | Neurology | Nuclear Medicine | Pathology | Study | Universities & Medical Training